Axel Vater Selected Research

NOX-D20

12/2013

A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Axel Vater Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 12/2010
4	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2013
3	Inflammation (Inflammations) 05/2017 - 07/2011
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
2	Sepsis (Septicemia) 01/2020 - 12/2013
2	Headache (Headaches) 01/2018 - 06/2006
2	Migraine Disorders (Migraine) 01/2018 - 11/2003
2	Disease Progression 05/2015 - 03/2014
2	Arthritis (Polyarthritis) 03/2014 - 12/2009
2	Experimental Arthritis 03/2014 - 12/2009
2	Rheumatoid Arthritis 03/2014 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 07/2013 - 07/2011
1	Pneumococcal Pneumonia 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2017
1	Colorectal Neoplasms (Colorectal Cancer) 11/2017
1	Retinal Degeneration 04/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Choroidal Neovascularization 10/2015
1	Cardiomyopathies (Cardiomyopathy) 05/2015
1	Fibrosis (Cirrhosis) 08/2014
1	Autoimmune Diseases (Autoimmune Disease) 08/2014
1	Alcoholism (Alcohol Abuse) 04/2014
1	Hyperglycemia 07/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2013
1	Rhabdomyosarcoma 07/2013
1	Airway Remodeling 04/2013
1	Pulmonary Hypertension 11/2012
1	Vascular Remodeling 11/2012
1	Body Weight (Weight, Body) 07/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2010
1	Adenocarcinoma 12/2010

Drug/Important Bio-Agent (IBA)

5	Complement C5a (Complement 5a)IBA 01/2022 - 04/2013
3	Complement System Proteins (Complement)IBA 12/2017 - 05/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2013
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2018 - 06/2006
2	AntibodiesIBA 01/2018 - 01/2017
2	Calcitonin Gene-Related PeptideIBA 01/2018 - 11/2003
2	NOX-A12IBA 11/2017 - 11/2012
2	Immune Checkpoint InhibitorsIBA 11/2017 - 01/2017
2	OligonucleotidesIBA 04/2017 - 10/2014
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	NOX-D21IBA 05/2017
1	sodium iodateIBA 04/2017
1	Retinaldehyde (Retinal)IBA 04/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	SphingolipidsIBA 08/2014
1	GhrelinIBA 04/2014
1	CollagenIBA 03/2014
1	Meloxicam (Mobic)FDA LinkGeneric 03/2014
1	Tramadol (K315)FDA LinkGeneric 03/2014
1	NOX-D20IBA 12/2013
1	Insulin (Novolin)FDA Link 07/2013
1	Glucagon Receptors (Glucagon Receptor)IBA 07/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	Glucagon (Glukagon)FDA Link 07/2013
1	Streptozocin (Streptozotocin)FDA Link 07/2013
1	Nucleotide AptamersIBA 07/2013
1	LipidsIBA 07/2013
1	Chemotactic FactorsIBA 07/2013
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2013
1	NOX-S93IBA 07/2013
1	MonocrotalineIBA 11/2012
1	ChemokinesIBA 07/2011
1	Blood Glucose (Blood Sugar)IBA 07/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2011
1	LigandsIBA 07/2011
1	Chemokine CXCL12IBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	PolyethyleneimineIBA 12/2010
1	Transcription Factors (Transcription Factor)IBA 12/2010
1	Immunoglobulin FragmentsIBA 12/2009
1	Fibronectins (Fibronectin)IBA 12/2009
1	Extracellular Matrix ProteinsIBA 12/2009

Therapy/Procedure

5	Therapeutics 11/2017 - 06/2006
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Lasers (Laser) 10/2015
1	Intradermal Injections 03/2014
1	Ligation 12/2013
1	Punctures 12/2013
1	Drug Therapy (Chemotherapy) 07/2013